<DOC>
	<DOC>NCT01236768</DOC>
	<brief_summary>The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.</brief_summary>
	<brief_title>Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm</brief_title>
	<detailed_description>Comparative evaluation of AG200-15 versus OC with regard to safety, contraceptive efficacy, hormone related adverse events, lipid profile, cycle control (bleeding pattern), subject compliance and serum concentrations of EE and LNG. To evaluate TCDS wearability (including adhesion).</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives, Oral, Hormonal</mesh_term>
	<criteria>sexually active women requesting contraception Regular menses every 24 35 days In good general health, confirmed by medical history, physical (including gynecologic examination adn screening laboratory values Known or suspected pregnancy Lactating women Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic) Use of other contraceptive methods than study medication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Contraceptive</keyword>
</DOC>